Published in PLoS One on November 08, 2011
HCV and oxidative stress in the liver. Viruses (2013) 1.28
HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells. Viruses (2015) 0.96
Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma. Free Radic Biol Med (2014) 0.94
Variation in RNA virus mutation rates across host cells. PLoS Pathog (2014) 0.89
Mechanisms of viral mutation. Cell Mol Life Sci (2016) 0.85
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol (2016) 0.85
Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress. Oxid Med Cell Longev (2013) 0.81
Interplay between Inflammation and Cellular Stress Triggered by Flaviviridae Viruses. Front Microbiol (2016) 0.77
Hepatitis C, innate immunity and alcohol: friends or foes? Biomolecules (2015) 0.77
Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus. J Biol Chem (2015) 0.76
Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget (2016) 0.75
Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res (2017) 0.75
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res (1982) 11.72
Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem (1998) 4.05
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A (2005) 3.83
Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem (2004) 3.54
Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. Hepatology (2007) 2.70
Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J Virol (2007) 2.45
Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol (1998) 2.37
Theory of lethal mutagenesis for viruses. J Virol (2007) 2.20
Hepatitis C virus resistance to protease inhibitors. J Hepatol (2011) 2.18
Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci (2002) 1.94
Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model. J Virol (2004) 1.93
The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res (1999) 1.82
Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Virology (2007) 1.74
Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology (2004) 1.71
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Selection for robustness in mutagenized RNA viruses. PLoS Genet (2007) 1.58
Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology (2010) 1.51
Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. Gastroenterology (2001) 1.45
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors. J Hepatol (2010) 1.43
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy. Hepatology (2008) 1.39
A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach. PLoS Pathog (2010) 1.38
Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells. Hepatology (2001) 1.34
Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A. PLoS One (2010) 1.29
Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci (2010) 1.29
Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA. J Virol (2005) 1.28
Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology (2010) 1.25
Quasispecies and its impact on viral hepatitis. Virus Res (2007) 1.19
Role of free radicals in viral pathogenesis and mutation. Rev Med Virol (2001) 1.14
Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol (2004) 1.13
Alcohol potentiates hepatitis C virus replicon expression. Hepatology (2003) 1.11
Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology (1994) 1.10
Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. J Clin Virol (2005) 1.08
Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proc Natl Acad Sci U S A (2007) 1.07
Determinations of ethanol, acetaldehyde and acetate in blood and urine during alcohol oxidation in man. Alcohol Alcohol (1989) 1.06
Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology (2003) 1.06
Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol (1996) 1.05
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology (2000) 1.04
The nature of interferon-alpha resistance in hepatitis C virus infection. Curr Opin Infect Dis (2003) 1.04
Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med (2007) 1.04
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenterology (2010) 1.03
A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. J Hepatol (1998) 1.02
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob Agents Chemother (2007) 1.01
Hepatitis C virus variability: sequence analysis of an isolate after 10 years of chronic infection. Virus Genes (2000) 1.01
Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase. Hepatology (2009) 1.01
Nickel-induced oxidative stress in testis of mice: evidence of DNA damage and genotoxic effects. J Androl (2004) 0.99
Biochemical characterization of the fidelity of poliovirus RNA-dependent RNA polymerase. Virol J (2007) 0.99
N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. J Interferon Res (1993) 0.99
Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol (1999) 0.98
Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial. Antiviral Res (1999) 0.96
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption. Dig Liver Dis (2001) 0.94
Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J Biol Chem (2009) 0.93
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation. Vaccine (2009) 0.90
There is not simple method to maintain a constant ethanol concentration in long-term cell culture: keys to a solution applied to the survey of astrocytic ethanol absorption. Alcohol (1997) 0.90
Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. J Virol (2008) 0.89
S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse. PLoS One (2010) 0.88
Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication. J Viral Hepat (2006) 0.88
Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity. J Viral Hepat (2007) 0.87
Effects of alcohol on the replication of hepatitis C virus. Alcohol Alcohol Suppl (1993) 0.87
Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies. Vaccine (2010) 0.86
Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology (1999) 0.86
Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases. J Viral Hepat (1996) 0.86
The base substitution fidelity of HIV-1 reverse transcriptase on DNA and RNA templates probed with 8-oxo-deoxyguanosine triphosphate. Mutat Res (1999) 0.85
Redox modulation of the hepatitis C virus replication complex is calcium dependent. Free Radic Biol Med (2006) 0.85
Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients. J Gastroenterol Hepatol (2001) 0.84
Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol (1997) 0.83
Incorporation of 8-hydroxyguanosine (8-oxo-7,8-dihydroguanosine) 5'-triphosphate by bacterial and human RNA polymerases. Free Radic Biol Med (2009) 0.81
Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption. J Viral Hepat (2006) 0.81
Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial. J Clin Apher (2009) 0.81
Ligand-independent tyrosine kinase signalling in RTH 149 trout hepatoma cells: comparison among heavy metals and pro-oxidants. Cell Physiol Biochem (2003) 0.79
Isolation and gene analysis of interferon alpha-resistant cell clones of the hepatitis C virus subgenome. Virology (2008) 0.77
Emergence of mutation clusters in the HCV genome during sequential viral passages in Sip-L expressing cells. J Virol Methods (2005) 0.77
Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death. J Gastroenterol Hepatol (2006) 0.77
Effect of ethanol on nuclear casein kinase II activity in brain. Neurochem Res (1997) 0.76
Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology (2008) 2.66
Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology (2008) 2.10
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother (2005) 1.88
Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci (2005) 1.83
Evolution of the serine beta-lactamases: past, present and future. Drug Resist Updat (2004) 1.77
Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol Rev (2010) 1.60
A robust small-molecule microarray platform for screening cell lysates. Chem Biol (2006) 1.52
Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol (2005) 1.45
Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci (2007) 1.41
Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials. Small (2006) 1.39
Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem (2010) 1.36
Growth rates made easy. Mol Biol Evol (2013) 1.29
The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. PLoS One (2011) 1.28
Revised Ambler classification of {beta}-lactamases. J Antimicrob Chemother (2005) 1.27
Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology (2010) 1.25
Skeletal diversity via a branched pathway: efficient synthesis of 29 400 discrete, polycyclic compounds and their arraying into stock solutions. J Am Chem Soc (2002) 1.24
Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol (2007) 1.22
Orphan nuclear receptor estrogen-related receptor γ (ERRγ) is key regulator of hepatic gluconeogenesis. J Biol Chem (2012) 1.18
Phylogenetic analysis as a tool in molecular epidemiology of infectious diseases. Ann Epidemiol (2005) 1.13
A practical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem Commun (Camb) (2007) 1.05
Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med (2007) 1.04
The metallo-beta-lactamases fall into two distinct phylogenetic groups. J Mol Evol (2003) 1.03
The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo. J Virol (2004) 1.03
Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. J Microbiol (2012) 1.02
Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation. J Biol Chem (2009) 1.02
Bioinspired polymerization of dopamine to generate melanin-like nanoparticles having an excellent free-radical-scavenging property. Biomacromolecules (2011) 1.02
Hypoxia induces PDK4 gene expression through induction of the orphan nuclear receptor ERRγ. PLoS One (2012) 1.02
Hepatitis C virus f protein is a short-lived protein associated with the endoplasmic reticulum. J Virol (2003) 1.01
The peaks and geometry of fitness landscapes. J Theor Biol (2012) 1.00
Crystal structure of Tpa1 from Saccharomyces cerevisiae, a component of the messenger ribonucleoprotein complex. Nucleic Acids Res (2009) 1.00
Expanding the functional group compatibility of small-molecule microarrays: discovery of novel calmodulin ligands. Angew Chem Int Ed Engl (2003) 0.99
Estrogen-related receptor γ (ERRγ) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling. J Biol Chem (2011) 0.99
Structure-based phylogenies of the serine beta-lactamases. J Mol Evol (2003) 0.99
Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg Infect Dis (2006) 0.97
Diversity-oriented synthesis of privileged benzopyranyl heterocycles from s-cis-enones. J Org Chem (2008) 0.96
GeneHunter, a transposon tool for identification and isolation of cryptic antibiotic resistance genes. Antimicrob Agents Chemother (2003) 0.95
Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrob Agents Chemother (2005) 0.95
Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes. PLoS One (2013) 0.94
Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J Biol Chem (2009) 0.93
Fitness trade-offs in blaTEM evolution. Antimicrob Agents Chemother (2008) 0.93
Inverse agonist of nuclear receptor ERRγ mediates antidiabetic effect through inhibition of hepatic gluconeogenesis. Diabetes (2013) 0.90
Independent origins of subgroup Bl + B2 and subgroup B3 metallo-beta-lactamases. J Mol Evol (2004) 0.90
Development of a cy3-labeled glucose bioprobe and its application in bioimaging and screening for anticancer agents. Angew Chem Int Ed Engl (2007) 0.89
Evolution and recombination of the plasmidic qnr alleles. J Mol Evol (2008) 0.89
Concise and diversity-oriented synthesis of novel scaffolds embedded with privileged benzopyran motif. Chem Commun (Camb) (2006) 0.89
Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models. Int J Cancer (2011) 0.89
A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma. Diabetes (2011) 0.88
Using complete genome comparisons to identify sequences whose presence accurately predicts clinically important phenotypes. PLoS One (2013) 0.88
Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging. Biomacromolecules (2013) 0.87
Fluorescent probe for detection of fluoride in water and bioimaging in A549 human lung carcinoma cells. Chem Commun (Camb) (2009) 0.87
Biomimetic asymmetric total synthesis of (-)-laurefucin via an organoselenium-mediated intramolecular hydroxyetherification. J Am Chem Soc (2008) 0.86
Recombination and selection can remove blaTEM alleles from bacterial populations. Antimicrob Agents Chemother (2008) 0.86
Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction. Br J Haematol (2009) 0.86
Practical solid-phase parallel synthesis of Delta(5)-2-oxopiperazines via N-acyliminium ion cyclization. J Comb Chem (2007) 0.85
Enhanced efficacy of 7-hydroxy-3-methoxycadalene via glycosylation in in vivo xenograft study. Bioorg Med Chem Lett (2007) 0.85
Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. Angew Chem Int Ed Engl (2012) 0.85
De novo analysis of protein N-terminal sequence utilizing MALDI signal enhancing derivatization with Br signature. Anal Bioanal Chem (2011) 0.85
Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces. J Am Chem Soc (2014) 0.84
Nitric oxide-induced resistance to hydrogen peroxide stress is a glutamate cysteine ligase activity-dependent process. Free Radic Biol Med (2005) 0.84
Rational perturbation of the fluorescence quantum yield in emission-tunable and predictable fluorophores (Seoul-Fluors) by a facile synthetic method involving C-H activation. Angew Chem Int Ed Engl (2014) 0.83
Emission wavelength prediction of a full-color-tunable fluorescent core skeleton, 9-aryl-1,2-dihydropyrrolo[3,4-b]indolizin-3-one. J Am Chem Soc (2011) 0.83
Chemistry as a prism: a review of light-emitting materials having tunable emission wavelengths. Chem Asian J (2009) 0.83
A two-photon tracer for glucose uptake. Angew Chem Int Ed Engl (2009) 0.83
Hyperthermic stress-induced increase in the expression of glutamate-cysteine ligase and glutathione levels in the symbiotic sea anemone Aiptasia pallida. Comp Biochem Physiol B Biochem Mol Biol (2008) 0.83
Synthesis and in vitro photodynamic activities of water-soluble fluorinated tetrapyridylporphyrins as tumor photosensitizers. Bioorg Med Chem Lett (2007) 0.83
Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med (2009) 0.82
Abc amino acids: design, synthesis, and properties of new photoelastic amino acids. J Org Chem (2006) 0.82
An efficient one-step synthesis of heterobiaryl pyrazolo[3,4-b]pyridines via indole ring opening. Org Lett (2009) 0.82
Regioselective synthesis of tetrasubstituted pyrroles by 1,3-dipolar cycloaddition and spontaneous decarboxylation. Org Lett (2009) 0.81
Efficient discovery of selective small molecule agonists of estrogen-related receptor gamma using combinatorial approach. J Comb Chem (2009) 0.81
Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRgamma). Biochem Biophys Res Commun (2007) 0.81
Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells. Chemistry (2011) 0.81
Clustering acinetobacter strains by optical mapping. Genome Biol Evol (2013) 0.81
Combinatorial discovery of full-color-tunable emissive fluorescent probes using a single core skeleton, 1,2-dihydropyrrolo[3,4-beta]indolizin-3-one. J Am Chem Soc (2008) 0.81
Diastereoselective synthesis of polycyclic acetal-fused pyrano[3,2-c]pyran-5(2H)-one derivatives. J Org Chem (2009) 0.80
A Seoul-Fluor-based bioprobe for lipid droplets and its application in image-based high throughput screening. Chem Commun (Camb) (2012) 0.80
Discovery of a novel Her-1/Her-2 dual tyrosine kinase inhibitor for the treatment of Her-1 selective inhibitor-resistant non-small cell lung cancer. J Med Chem (2009) 0.80
A synthetic route to highly substituted 1,2,3,4-tetrahydroisoquinolines via Yb(OTf)3 -catalyzed diastereoselective ring opening of bridged oxazolidines: asymmetric synthesis of 2-azapodophyllotoxin. Chemistry (2011) 0.80
Development of a benzopyran-containing androgen receptor antagonist to treat antiandrogen-resistant prostate cancer. ChemMedChem (2010) 0.79
Lentiviral vector-mediated shRNA against AIMP2-DX2 suppresses lung cancer cell growth through blocking glucose uptake. Mol Cells (2012) 0.79
Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay. J Med Chem (2014) 0.79
Synthesis and library construction of privileged tetra-substituted Δ5-2-oxopiperazine as β-turn structure mimetics. ACS Comb Sci (2013) 0.79
Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4. J Mol Cell Cardiol (2013) 0.79
Optimization of Seoul-Fluor-based lipid droplet bioprobes and their application in microalgae for bio-fuel study. Mol Biosyst (2013) 0.79
Crystallization and preliminary X-ray diffraction analysis of importin-alpha complexed with NLS peptidomimetics. Biochim Biophys Acta (2005) 0.79
Efficient parallel synthesis of privileged benzopyranylpyrazoles via regioselective condensation of beta-keto aldehydes with hydrazines. J Comb Chem (2009) 0.79
A selective Seoul-Fluor-based bioprobe, SfBP, for vaccinia H1-related phosphatase--a dual-specific protein tyrosine phosphatase. Chem Commun (Camb) (2012) 0.79
A design strategy for drug-like polyheterocycles with privileged substructures for discovery of specific small-molecule modulators. Chem Commun (Camb) (2011) 0.78
Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases. J Med Chem (2012) 0.78
Surface modification for small-molecule microarrays and its application to the discovery of a tyrosinase inhibitor. Mol Biosyst (2010) 0.78
Construction of a polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway. J Comb Chem (2010) 0.78
From noncovalent to covalent bonds: a paradigm shift in target protein identification. Mol Biosyst (2013) 0.78
Unique photophysical properties of 9-styryl-1,2-dihydropyrrolo[3,4-β]indolizin-3-one and its efficient synthesis via direct C-H activation. Org Biomol Chem (2015) 0.78
Anti-obesity agents: a focused review on the structural classification of therapeutic entities. Curr Top Med Chem (2009) 0.78
Synthesis and biological evaluation of α-galactosylceramide analogues with heteroaromatic rings and varying positions of a phenyl group in the sphingosine backbone. J Med Chem (2013) 0.77
Impact of molecular charge on GLUT-specific cellular uptake of glucose bioprobes and in vivo application of the glucose bioprobe, GB2-Cy3. Chem Commun (Camb) (2014) 0.77
Nonspecific protein labeling of photoaffinity linkers correlates with their molecular shapes in living cells. Chem Commun (Camb) (2016) 0.76
A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice. Mol Pharmacol (2010) 0.76
Phosphorylation analysis of hepatitis B virus core protein in mammalian cells. Methods Mol Med (2004) 0.76
Small molecule microarray: functional-group specific immobilization of small molecules. Methods Mol Biol (2010) 0.76